๐ŸŽ Black Friday: up to 50% off of annual plans
Aspira Pathlab & Diagnostics Limited (BOM:540788)
India flag India ยท Delayed Price ยท Currency is INR
131.00
-4.65 (-3.43%)
At close: Nov 20, 2026

BOM:540788 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
240.71249.82219.99132.05144.57195.42
Revenue Growth
-1.85%13.56%66.60%-8.66%-26.02%28.52%
Gross Profit
74.8799.9397.0934.1755.9499.8
Operating Income
-35.21-0.7520.63-27.260.0847.38
Net Income
-34.510.5120.73-26.72-0.8944.59
Earnings Per Share
-3.350.052.01-2.60-0.094.33
EPS Growth
--97.52%---198.62%

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
7.6316.821.4413.8423.4916.44
Total Debt
45.3133.2231.9627.8233.1439.22
Net Cash (Debt)
-37.68-16.42-10.52-13.98-9.64-22.78
Net Cash Growth
------
Net Cash Per Share
-3.66-1.60-1.02-1.36-0.94-2.21

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
21.0514.5418.7710.54-0.1220.31
Capital Expenditures
-11.96-6.96-3.44-2.62-1.31-5.99
Free Cash Flow
9.097.5815.337.92-1.4314.32
Free Cash Flow Growth
--50.54%93.62%---74.19%

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
31.10%40.00%44.14%25.88%38.69%51.07%
Operating Margin
-14.63%-0.30%9.38%-20.64%0.05%24.24%
Pretax Margin
-14.34%0.21%9.42%-20.24%-0.61%22.82%
Profit Margin
-14.34%0.21%9.42%-20.24%-0.61%22.82%
FCF Margin
3.77%3.03%6.97%6.00%-0.99%7.33%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-1120.5942.33--14.96
P/FCF Ratio
148.4275.8457.2440.31-46.56
PS Ratio
5.602.303.992.421.983.41